|
Volumn 10, Issue 9, 2002, Pages 2927-2932
|
Design, synthesis, and biological evaluation of a cephalosporin-monohydroguaiaretic acid prodrug activated by a monoclonal antibody-β-lactamase conjugate
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (3,4 DIMETHOXYPHENYL)DIMETHYL 4 [3 METHOXY 4 (7 PHENOXYACETAMIDO) (1 OXO) 3 CEPHEN 4 HYDROXYCARBONYL 3 METHOXYPHENYL]BUTANE;
ANTINEOPLASTIC AGENT;
BETA LACTAMASE;
CEPHALOSPORIN DERIVATIVE;
HYBRID PROTEIN;
MONOCLONAL ANTIBODY;
NORHYDROGUAIARETIC ACID;
PRODRUG;
PROTEIN DSFV3 BETA LACTAMASE;
UNCLASSIFIED DRUG;
ANTIBODY CONJUGATE;
CANCER ANTIBODY;
NORDIHYDROGUAIARETIC ACID;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CARCINOMA;
CANCER CELL;
COLON CANCER;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SCREENING;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG SYNTHESIS;
EMBRYO CELL;
FIBROBLAST;
HUMAN;
HUMAN CELL;
IC 50;
LEUKEMIA;
LUNG CANCER;
PANCREAS CANCER;
PROTON NUCLEAR MAGNETIC RESONANCE;
CELL CULTURE;
CELL DIVISION;
DRUG EFFECT;
DRUG POTENTIATION;
HYDROLYSIS;
IMMUNOLOGY;
METABOLISM;
SYNTHESIS;
ANTIBODIES, NEOPLASM;
ANTINEOPLASTIC AGENTS;
BETA-LACTAMASES;
CELL DIVISION;
CEPHALOSPORINS;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
DRUG SYNERGISM;
HUMANS;
HYDROLYSIS;
IMMUNOCONJUGATES;
NORDIHYDROGUAIARETIC ACID;
PRODRUGS;
TUMOR CELLS, CULTURED;
|
EID: 18444395235
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00140-2 Document Type: Article |
Times cited : (6)
|
References (51)
|